Zamora, Geraldine B.

HRN: 21-16-98  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2022
CEFUROXIME 750MG (VIAL)
04/20/2022
04/26/2022
IVT
750mg
Q8hours
IUFD

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Non-compliant To Guidelines